MiniMed Group, Inc. (MMED)
NASDAQ
Closed
Aug 24, 2026
Day's Range
19.6452 wk Range
10.65Profile - MMED - MiniMed Group, Inc.
Profile
Mic Code
XNMS
Sector
Healthcare
Industry
Health Information Services
Employees
8K
MiniMed Group, Inc. is a global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for diabetes management. It offers a connected ecosystem of products including automated insulin delivery systems like the MiniMed 780G system with SmartGuard technology for real-time glucose stabilization, InPen smart insulin pens for intelligent dosing support, insulin pumps, continuous glucose monitors, consumables, supplies, related software, and services. These technologies emphasize adaptive, simplified, and reliable care, allowing users to manage diabetes more seamlessly across daily life. Operating in approximately 80 countries, MiniMed Group, Inc. supports diverse preferences such as durable pumps, patch pumps, and app-integrated options, backed by a team of engineers, clinicians, and individuals with diabetes experience. Founded in 1983 and headquartered in Northridge, California, it focuses on relentless innovation in the healthcare sector's medical instruments and supplies industry to enhance outcomes for people requiring intensive insulin therapy.
Profile Details
Type
Common Stock
Ceo
Ms. Que Thanh Dallara
Address
18000 Devonshire Street
City
Northridge
State
CA
Zip
91325
Country
United States
Phone
(763) 514-4000
Key Executives - MMED - MiniMed Group, Inc.
Key executives
Cross Listings - MMED - MiniMed Group, Inc.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
